135 results
Page 5 of 7
8-K
oge9spw1t4pk0o
19 Nov 21
Other Events
6:03am
8-K
5dlzsnno
8 Nov 21
FDA Grants Tentative Approval for Liquidia’s
4:16pm
8-K
EX-99.1
ki85hu
8 Nov 21
FDA Grants Tentative Approval for Liquidia’s
4:16pm
8-K
EX-99.1
c1761t0btip6j29p8rn
13 Oct 21
Liquidia Receives Favorable Ruling in Inter Partes Review
12:00am
424B3
co90yq412ckj z21
22 Sep 21
Prospectus supplement
4:06pm
8-K
EX-10.1
crh5j j1w
30 Aug 21
Entry into a Material Definitive Agreement
4:29pm
8-K
EX-99.1
1j5l0
19 Aug 21
FDA Completes On-site Pre-Approval Inspection of
4:05pm
8-K
EX-99.1
sxa e5hkxg
12 Aug 21
U.S. Patent Trial and Trademark Appeal Board Decides to Institute
4:57pm
8-K
EX-99.1
dzdeu
2 Jun 21
Liquidia Announces FDA Acceptance of New Drug Application Resubmission for LIQ861 (treprostinil) Inhalation Powder
7:31am
8-K
EX-99.1
tkb24xd
24 May 21
Liquidia Announces Generic Treprostinil Injection Now Also Available for Subcutaneous Route of Administration
4:07pm
10-Q
ick p9893gv7u6zly
13 May 21
Quarterly report
4:02pm
8-K
EX-99.1
a971inavzzn9ab11 jdw
13 May 21
Liquidia Reports First Quarter 2021 Financial Results
7:15am
8-K
EX-99.1
rtj4r5f kavy
10 May 21
Liquidia Resubmits New Drug Application for LIQ861 (treprostinil) Inhalation Powder for the Treatment of Pulmonary Arterial Hypertension
6:36am
DEF 14A
bdvaubp 74k35g3cm
30 Apr 21
Definitive proxy
4:28pm
8-K
EX-10.2
2cgv5769
13 Apr 21
Liquidia Corporation Announces $21.7 Million Private Placement
8:42am
10-K
EX-10.23
s7x sok9of89
25 Mar 21
Annual report
5:01pm
10-K
ycm3s1kdgyb275b
25 Mar 21
Annual report
5:01pm